Research & Development



  謝長川長嘆一聲道︰“老夫還是第一次覺得我們快要結束白登山的戰爭了。”   司馬遷說的似乎很有道理……色窝综合网   他們舉著簡陋木頭盾牌,抬著梯子哇哇怪叫著一次又一次的如同浪潮一般拍擊著城牆。得得去,得得干   於單的聲音不算小,所以听見這句話的人不少,其中就有兩個不參與祭祀的鬼巫。   “山門中人算什麼女人!”得得去在线

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo